Authors/Disclosures
|
Nicola Pavese, MD
(Newcastle University)
|
Dr. Pavese has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. The institution of Dr. Pavese has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bial. Dr. Pavese has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AbbVie. Dr. Pavese has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Britannia. The institution of Dr. Pavese has received research support from Multiple System Atrophy Trust. The institution of Dr. Pavese has received research support from Parkinson's UK. The institution of Dr. Pavese has received research support from Independent Research Fund Denmark. The institution of Dr. Pavese has received research support from European Union. The institution of Dr. Pavese has received research support from MRC. |
|
Christopher Scherfler, MD
(PET Neurology)
|
No disclosure on file |
|
Naheed A. Khan, MD
(Institute of Neurology)
|
No disclosure on file |
|
Robert Y. Moore, MD, FAAN
|
No disclosure on file |
|
Gary Hotton, MBBS, BSc
|
No disclosure on file |
|
Danish Ghazali, MD
|
No disclosure on file |
|
Andrew J. Lees, MD, FRCP
(Reta Lila Weston Institute of Neurological Studies, IoN, UCL)
|
Dr. Lees has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Britannia. Dr. Lees has received personal compensation in the range of $5,000-$9,999 for serving as a Speaker with Bial Pharma. |
|
Niall P. Quinn, MD, FAAN
(Institute of Neurology)
|
No disclosure on file |
|
Nicholas W. Wood
(National Hospital for Neuro.)
|
No disclosure on file |
|
David J. Brooks, MD, DSc, FRCP
(Imperial College London)
|
No disclosure on file |
|
Paola Piccini, MD
(Hammersmith Hospital)
|
No disclosure on file |
|
Jan H. Veldink, MD, PhD
|
The institution of Dr. Veldink has received research support from Biogen. |